StreetAlpha.app
Home › Stocks › NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

$0.71
▼ −5.15%
LAST CLOSE · NOV 17

NeuroOne Medical Technologies makes brain electrodes and nerve ablation systems for surgeons and pain specialists. It last closed at $0.71 on Nov 17, down 5.15% on the day. NMTC reports earnings on Tue, Dec 15, 2026.

AI Auto Pilots
Is NMTC in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$9.5M
+42.8% vs a year ago
Net income
−$7.4M
−78.6% margin
EPS (diluted)
−$0.52
Free cash flow
−$7.2M
−75.6% margin
Valuation
Market cap
$6.4M
9.1M shares
P/E
–
No P/E while losing money
Price to sales
0.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$2.0M
At Jun 30
Shareholder equity
$3.8M
Shares outstanding
9.1M
At Aug 11
Fiscal year endsSeptember
ExchangeNasdaq
Financials history
FY2021: $178K$178KFY2021FY2022: $171K$171KFY2022FY2023: $2.0M$2.0MFY2023FY2024: $3.5M$3.5MFY2024FY2025: $9.1M$9.1MFY2025

From NMTC's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 13). Last 12 months adds up the four latest quarters.

Next report
Dec 15
2026 · Time not announced
Consensus EPS forecast
-$0.19
$3.2M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated NMTC in the past 90 days.
Average 12-month target
No price targets on NMTC in the past 90 days.
Latest rating changes
Maxim GroupMaintained
Aug 14Buy$5
DateFirmActionRatingPrice target
Aug 14Maxim GroupMaintainedBuy$5
Loading…

Technical Analysis

NMTC · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 22% below its 20 day and 53% below its 50 day average. It is 315% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 29), oversold. The nearest support is the Pivot S1 at $0.68, and the nearest resistance the 52 week low at $0.71.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 13.3%/day
Key levels
$6.1252 week high+762.0%
$2.93200 day average+312.7%
$1.59100 day average+123.9%
$1.0850 day average+52.1%
$1.04Swing high (Oct 29)+46.5%
$0.8620 day average+21.1%
$0.76Pivot R1+7.0%
$0.73Pivot+2.8%
$0.7152 week low+0.0%
$0.71Last close
$0.68Pivot S1−4.2%
Indicators
RSI (14)29.27Oversold below 30Oversold
MACD-0.10Below its signal lineBearish
Stochastic0.0Near the bottom of its rangeOversold
ADX (14)9.3No clear trend
Williams %R-100.0Oversold below −80, overbought above −20Oversold
CCI (20)-132.1Oversold below −100, overbought above 100Oversold
Rate of change−27.9%Change over 10 sessionsBearish
ATR (14)$0.09Typical daily range, 13.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for NMTC

What happened before

See how NMTC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow NMTC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How NMTC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in NMTC in the last 90 days.

Loading…

See today’s whale options flow across the market →

NMTC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼8 buying vs 13 selling
  • ▼Held by funds -5.3 pts
  • ▼Funds holding -3
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2225−12.0%
In funds' top 1000–
Held by funds17.5%22.7%−5.3 pts
New / increased5 / 324 / 0−66.7%
Reduced / sold out5 / 81 / 0+1200.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NMTC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NMTC is in one of them and how their past NMTC trades turned out.

NMTC in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NMTC in an article yet. Here's the latest on the wider market.

About NEUROONE MEDICAL TECHNOLOGIES

NeuroOne Medical Technologies is a medical technology company based in Eden Prairie, Minnesota. It makes thin film electrodes that record and stimulate brain activity during surgery, along with radiofrequency ablation systems used to treat epilepsy and nerve pain. Its customers are mainly neurosurgeons, neurologists, pain management physicians and hospitals. The company is also developing spinal cord stimulation and drug delivery devices that are not yet sold.

Headquarters
Eden Prairie, MN